|
KROS Keros Therapeutics Inc 1664710 |
| Balance Sheet |
|
Current Assets
|
552,046,000 |
|
Assets
|
579,271,000 |
|
Current Liabilities
|
29,007,000 |
|
Liabilities
|
46,436,000 |
|
Equity
|
532,835,000 |
|
Shares Out
|
37,522,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-114,861,000 |
|
Investing Cash Flow
|
-1,642,000 |
| Market Analysis |
Market Cap
|
2,065,215,867 |
|
Price
|
10.86 |
|
BVPS
|
14.20 |
|
PB
|
0.76 |
|
EPS
|
-5.13 |
|
PS
|
1330.68 |
|
FCF
|
-116,503,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KROS documents filed with the SEC.
KROS Filings
Clear
